The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
93.394 |
RFA-CA-25-007 |
| NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional) |
93.273, 93.279, 93.847, 93.855 |
PA-25-249 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
93.394 |
RFA-CA-25-005 |
| Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) |
93.242 |
PAR-25-283 |
| Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) |
93.242 |
PAR-25-284 |
| Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) |
93.855 |
PAR-25-099 |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-25-056 |
| Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-074 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) |
93.866 |
PAR-25-331 |
| Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) |
93.865 |
PAR-25-362 |
| Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional) |
93.307, 93.867 |
RFA-EY-25-002 |
| Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) |
93.866 |
PAR-25-374 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
93.279 |
PAR-25-101 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
93.853, 93.866 |
PAR-25-332 |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) |
93.350 |
PAR-25-195 |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) |
93.350 |
PAR-25-194 |
| Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) |
93.853 |
PAR-25-327 |
| Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-25-316 |
| Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-25-315 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) |
93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.361, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867 |
PA-25-307 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) |
93.113, 93.143, 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.286, 93.361, 93.837, 93.838, 93.839, 93.840, 93.855, 93.865, 93.866, 93.867, 93.879 |
PA-25-306 |
| NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.865, 93.866, 93.867 |
PA-25-303 |
| Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) |
93.853 |
PAR-25-326 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.143, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-25-301 |
| NIH Research Project Grant (Parent R01 Clinical Trial Required) |
93.113, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-25-305 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-25-032 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) |
93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.837, 93.838, 93.839, 93.840, 93.855, 93.865, 93.866, 93.867, 93.879 |
PA-25-304 |
| NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-26-006 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
93.113, 93.143, 93.172, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.837, 93.838, 93.839, 93.840, 93.853, 93.855, 93.865, 93.866, 93.879 |
PA-25-302 |
| NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional) |
93.173 |
RFA-DC-25-004 |
| HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) |
93.213, 93.242, 93.273, 93.279, 93.865, 93.866 |
RFA-DA-25-078 |
| HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) |
93.213, 93.242, 93.273, 93.279, 93.865, 93.866 |
RFA-DA-25-077 |
| Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) |
93.399 |
RFA-CA-25-019 |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) |
93.172 |
RFA-HG-25-009 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) |
93.395 |
PAR-25-336 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-002 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-004 |
| NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) |
93.173 |
RFA-DC-25-002 |
| Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-25-023 |
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-25-011 |
Search Results 281-320 of 15496
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 [Next] |
